LOUISVILLE, Ky. -- Large tumor size and high disease grade were associated with an increased risk of early cancer-related ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

An FDA panel on Thursday endorsed a cryoablation system as an alternative to surgery for some early breast cancer patients.

Bristol-Myers Squibb has revealed that its checkpoint inhibitor combination of Opdivo and Yervoy failed a phase 3 trial as adjuvant (post-surgery) therapy for renal cell carcinoma (RCC), the most ...

We spoke to our expert Dr Sachin Trivedi, Director, Medical Oncology, HCG Cancer Center, Colaba, who explained that adjuvant chemotherapy, which is chemotherapy administered after surgery ...

Patients with early breast cancer who are at risk of late relapse after breast-conserving surgery may derive little benefit from adjuvant radiotherapy, research suggests.

Perioperative chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC) shows promising long-term benefits with ...

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

Atossa Therapeutics has strong financials with $79.5 million in cash and a cash runway of 13-14 quarters, minimizing ...

Patients with dMMR colon cancer in a trial for two neoadjuvant cycles of nivolumab/ipilimumab or nivolumab/relatlimab, had ...

In both groups, 87.5% received R0/R1 surgery, and the median dose of radiation therapy was 60 Gy in the pembrolizumab group ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...